SN.L vs ZBH
SN.L: A global medical technology leader focused on restoring patient mobility through advanced orthopedic, sports medicine, and wound care solutions. ZBH: A global medical device company focused on musculoskeletal healthcare, including orthopedic implants and advanced surgical technologies.
Side-by-side fundamentals
| Metric | SN.L | ZBH | Edge |
|---|---|---|---|
| Price | £10.19 | $88.88 | |
| Market cap as of 2026-07-30 (share count; price 2026-10-08) | n/a | $17.0B | |
| P/E as of 2026-10-08 | n/a | 21.63 | |
| Net margin | +10.1% | +8.6% | SN.L higher |
| Gross margin FY to 2025-12-31, filed 2026-03-16 | +68.0% | n/a | |
| Operating margin FY2025, SEC XBRL | n/a | +13.3% | |
| ROE | +11.8% | +5.5% | SN.L higher |
| ROA FY2025, SEC XBRL | n/a | +3.1% | |
| Debt / equity as of 2026-09-02 | n/a | 0.59 | |
| Revenue growth (YoY) as of 2026-09-02 | n/a | +8.6% | |
| Revenue CAGR (3y) SEC XBRL | n/a | +5.9% | |
| Dividend yield as of 2026-09-02 | n/a | +1.0% | |
| Dividend streak (yrs) SEC XBRL | n/a | 15 | |
| Beta as of 2026-09-02 | n/a | 0.29 | |
| 1-year return | -23.8% | -9.6% | ZBH higher |
Fundamentals: SEC XBRL company filings and annual report filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-07.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.